[An experience with the use of direct renin inhibitor aliskiren in a patient with obesity and arterial hypertension].
M L
ML
Maksimov
O D
OD
Ostroumova
A K
AK
Starodubtsev
D000553:Ambulatory Care; D000577:Amides / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018660:Blood Pressure Monitoring, Ambulatory; D015992:Body Mass Index; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D005650:Fumarates / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D056128:Obesity, Abdominal / Q000150:complications* / Q000175:diagnosis; D020913:Perindopril / Q000008:administration & dosage / Q000627:therapeutic use; D017257:Ramipril / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D000092502:Renin Inhibitors
D000577:Amides; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D005650:Fumarates; D020913:Perindopril; D017257:Ramipril; D000092502:Renin Inhibitors; C446481:aliskiren